Lanwei Xu
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Immunology top 1%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Papers in
-
- Developmental Biology and Gene Regulation 16
- Cancer-related gene regulation 11
- Epigenetics and DNA Methylation 8
- Hematology 15
- Chronic Myeloid Leukemia Treatments 8
- Acute Myeloid Leukemia Research 6
- Co-authors
- Warren S. Pear (39 shared papers)Jon C. Aster (21 shared papers)Fredrick G. Karnell (8 shared papers)David Allman (6 shared papers)Sonia Bakkour (4 shared papers)Olga Shestova (14 shared papers)Ivan Maillard (8 shared papers)Avinash Bhandoola (6 shared papers)
- Journals
- Blood (15 papers)Immunity (3 papers)The Journal of Experimental Medicine (3 papers)Genes & Development (3 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesNetherlandsBrazil
In The Last Decade
Lanwei Xu
42 papers receiving 5.2k citations
Lanwei Xu's Hit Papers
Peers
Comparison fields: 5 of 93
- Hematology 1.4k
- Immunology 1.8k
- Genetics 537
- Molecular Biology 3.2k
- Cell Biology 537
Countries citing papers authored by Lanwei Xu
This map shows the geographic impact of Lanwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanwei Xu more than expected).
Fields of papers citing papers by Lanwei Xu
This network shows the impact of papers produced by Lanwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanwei Xu. The network helps show where Lanwei Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lanwei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Notch1 Expression in Early Lymphopoiesis Influences B versus T Lineage Determination Hit paper breakdown → | 1999 | 766 |
| 2 | Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow Hit paper breakdown → | 1998 | 627 |
| 3 | 2000 | 473 | |
| 4 | 2005 | 289 | |
| 5 | 2004 | 235 | |
| 6 | 2008 | 228 | |
| 7 | 2000 | 221 | |
| 8 | 2002 | 211 | |
| 9 | 2006 | 195 | |
| 10 | 2003 | 180 | |
| 11 | 2008 | 163 | |
| 12 | 2006 | 162 | |
| 13 | 2001 | 161 | |
| 14 | 2005 | 152 | |
| 15 | 2001 | 150 | |
| 16 | 2009 | 144 | |
| 17 | 2010 | 113 | |
| 18 | 2002 | 95 | |
| 19 | 2010 | 94 | |
| 20 | 2010 | 70 |
About Lanwei Xu
Lanwei Xu is a scholar working on Molecular Biology, Hematology, Immunology, Genetics and Oncology, having authored 43 papers that have together received 5.3k indexed citations. Recurring topics across this work include Developmental Biology and Gene Regulation (16 papers), Cancer-related gene regulation (11 papers), Epigenetics and DNA Methylation (8 papers), Chronic Myeloid Leukemia Treatments (8 papers), Acute Myeloid Leukemia Research (6 papers), T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Hematology (1.4k citations), Immunology (1.8k citations), Genetics (537 citations), Molecular Biology (3.2k citations) and Cell Biology (537 citations). Lanwei Xu has collaborated with scholars based in United States, Netherlands and Brazil. Frequent co-authors include Warren S. Pear, Jon C. Aster, Fredrick G. Karnell, David Allman, Sonia Bakkour, Olga Shestova, Ivan Maillard, Avinash Bhandoola, Yiping He and Juli P. Miller. Their work appears in journals such as Blood, Immunity, The Journal of Experimental Medicine, Genes & Development and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.